Objective. This study assessed the prevalence and associations of fatigue in systemic lupus erythematosus (SLE).
Fatigue is one of the commonest and often the most patients with quiescent lupus continue to experience marked fatigue. We have embarked upon a prospective disabling symptom experienced by individuals with systemic lupus erythematosus (SLE) and affects up to 80% study of potential therapies of fatigue in SLE. This study represents our baseline data on this population of patients [1] . In the majority of cases the cause of fatigue in SLE is not known. However, it is likely to and assesses the prevalence and severity of fatigue in out-patients with SLE and its relationship with disease result from a number of contributing factors, such as disease activity [1, 2, 3] , mood disorder [1, 4] , poor activity, disease damage, sleep disturbance, quality of life and mood. sleep patterns [4] , low levels of aerobic fitness [5] and associated fibromyalgia [6, 7] , whose relative influences will vary both among patients and within the same person over time. The relationship between fatigue and Methods disease activity is controversial. Wysenbeek et al. [2] We studied 120 consecutive female patients who fulfilled showed that SLE patients with fatigue had significantly the updated American College of Rheumatology classimore arthritis and lower lymphocyte counts than SLE fication criteria for SLE [10, 11] and were assessed patients who had no fatigue. There was also a significant during their out-patient clinic appointment at the correlation between fatigue and a disease activity index.
Connective Tissue Disease Clinic in the Rheumatology Similarly, Krupp et al. [1] showed a significant correlaDepartment of St Bartholomew's and The London NHS tion between fatigue and the physician's rating of disease Trust. Self-reported fatigue was measured using three activity and Zonana-Nacach et al. [3] showed a weak fatigue questionnaires: the Fatigue Severity Score (FSS) but significant correlation between fatigue and the [12], the Chalder Fatigue Scale (CFS) [13] and a visual Systemic Lupus Activity Measure (SLAM ). However, analogue scale ( VAS ) [14] . The FSS is a nine-item Wang et al. [8] and Bruce et al. [9] failed to show any questionnaire, each item being scored from 1 to 7 and association. There is a consensus, however, that even an overall score computed in the range of 1 to 7. The CFS is a 14-item questionnaire, each item being scored from 0 to 3, generating a score between 0 and 42. The after exertion, generating a total score of between 0 and 400 and also mental and physical fatigue component The median ECLAM score was 2.0 (1-8) and the median SLAM score was 6 (3-8). The median scores, each between 0 and 200. In all three fatigue questionnaires, a higher score indicates increasing sever-SLICC/ACR Damage Index score was 0 (0-1). These patients thus had mild, relatively early disease. There ity of fatigue. The FSS has been validated in SLE and the CFS and VAS have been validated and are widely was no significant correlation between fatigue and age, disease duration and SLICC/ACR Damage Index score. used in the field of chronic fatigue syndrome.
Disease activity was measured using the Systemic Sixty-one (51%) patients were taking prednisolone, at a median dose of 5 mg (interquartile range 0-7.5). Of Lupus Activity Measure (SLAM ) [15] and the European Consensus Lupus Activity Measure ( ECLAM ) [16 ] .
these 61 patients, 40 (33% of all the patients) were taking ∏7.5 mg/day and 21 (17.5%) were taking Both these measures include a component question on fatigue, which contributes to the total score. These >7.5 mg/day of prednisolone. Forty patients (33%) were taking azathioprine (100 or 150 mg), 52 (43%) were measures were chosen for two reasons: first, ECLAM is in routine clinical use in our clinic; secondly, both taking hydroxychloroquine (200 or 400 mg) and 15 (13%) were taking antidepressants. The patients taking SLAM and ECLAM have been shown to be the global score disease activity indices which are most sensitive to hydroxychloroquine had significantly higher fatigue scores than those not taking this drug (median FSS 5.89 change [17] . We plan to investigate both how fatigue and disease activity change over time and the effects of vs 5.27, P = 0.003; CFS 24 vs 20, P = 0.004; VAS total 317 vs 287, P = 0.003; Mann-Whitney test). There was possible therapies on fatigue in SLE. Disease damage was measured using the Systemic Lupus International no difference in fatigue scores between patients taking azathioprine and those not taking this drug (MannCollaborating Clinics (SLICC )/ACR Damage Index [18] . Quality of sleep was assessed using the Pittsburgh Whitney test). There was no significant difference in fatigue scores between patients not taking prednisSleep Quality Index (PSQI ) [19] . This is a self-rated questionnaire comprising 19 different items, generating olone, those taking ∏ 7.5 mg/day and those taking >7.5 mg/day ( Kruskal-Wallis test). an overall score between 0 and 21, a higher score indicating poorer sleep quality. Functional status was
The median fatigue, sleep and depression scores are shown in Table 1 . There was a strong correlation measured using the Medical Outcomes Study Short Form Health Survey (SF-36) [20] . This is a 36-item between scores for the three fatigue questionnaires (FSS vs CFS, r = 0.6, 95% confidence interval (CI ) 0.2-0.8; questionnaire generating component scores for physical function, physical role, bodily pain, general health, FSS vs VAS totals r = 0.6, 95% CI 0.2-0.8; CFS vs VAS totals r = 0.6 95% CI 0.2-0.8, P < 0.001). vitality, social function, emotional role and mental health. Each component score is between 0 and 100, a Scores for all three fatigue questionnaires correlated weakly but significantly with the disease activity scores higher score indicating better function. Anxious and depressed moods were assessed using the Hospital ( also performed to screen for thyroid disorders that might contribute to fatigue.
Normal or usual scores are up to 3 for the FSS, 14 for CFS, 200 for total VAS and 100 for physical and mental VAS. A score less than
Statistical analysis
8 on the HAD scale is considered non-pathological. A PSQI score less than 6 is considered non-pathological.
Statistical analysis was done using the SPSS 8.0 for Windows software package. The distribution of fatigue T 2. Correlation between fatigue and disease activity (n = 120) scores suggested that the data were not normally distributed and therefore non-parametric tests were used in all inactive SLE ( Table 3) .
Mental health 60 48-76 71.6 (17.8) All scores for the SF-36 components were low ( Table 4) , physical and emotional roles scoring the 100 is the maximum (full capacity) SF-36 score for physical and general health function components. lowest values. The FSS correlated with the PSQI scores, the HAD scores, and inversely with all components of the SF-36 ( Table 5) . Similar correlations were seen patients had an Hb concentration <9 g/dl. There was no significant correlation between Hb and any of the fatigue scores. Sixteen (13%) patients had an Hb concenDiscussion tration <11 g/dl. There was no significant difference in FSS, CFS or VAS total between those with an Hb Fatigue is a very common symptom in the SLE patients attending our out-patient clinics. We found that between concentration <11 g/dl and those with an Hb concentration Á 11g/dl (Mann-Whitney test). 80 and 90% of our patients reported abnormal fatigue, and this finding was consistent when we used different There were 76 (63%) patients for whom recent (within the last 6 months) thyroid function tests were available.
types of questionnaires to measure fatigue. This result is similar to those of other studies [1] and indicates These were borderline abnormal in three (4%) of the 76 patients, who had mild elevation of the thyrotropin significant morbidity from fatigue even in our cohort of out-patients with relatively mild, early disease. concentration (7.1, 6.8 and 5 .1 mU/l; normal range 0.3-4.0 mU/l ) and mildly low free thyroxine conOur cohort differs from others in the literature [22] in that this is an inception cohort in a newly established centrations (9.6, 9.1 and 10.8 pmol/l; normal range 11-25 pmol/l ).
connective tissue disease clinic. The patients are relatively young and have a short disease duration and older (mean age 43 yr) and had a longer disease duration (mean 12 yr) and more damage (mean SLICC score 1.5) low cumulative damage scores. The clinic philosophy is to keep disease activity and damage to a minimum by than those studied by Zonana-Nacach et al.
[3] and ourselves. Also, the SLAM includes, or weighs more using antimalarials and low-dose corticosteroids with immunosuppressives when indicated by multisystem heavily, more of the subjective aspects of disease activity than SLEDAI and has been shown to be the only disease.
There was good correlation between the three fatigue activity index in common use that correlates positively with the patient's global assessment of disease activity questionnaires. The CFS and VAS have been used extensively in the field of chronic fatigue syndrome but on a VAS [17] . Obviously, factors other than disease activity, such as poor sleep, mood disorder and possibly to date only the FSS has been used in SLE. The CFS and VAS are therefore tools that could be used in any low levels of aerobic fitness, must be contributing to fatigue, particularly in those with quiescent SLE. future research into fatigue in SLE.
In a small number of SLE patients fatigue may be Sleep quality explained partly by other physical problems. Three of our patients had biochemical evidence of subclinical Nearly two-thirds of our patients reported poor sleep quality, and this correlated moderately well with all the hypothyroidism, and this may have contributed to their fatigue. Anaemia is well known to be associated with fatigue scores. There are likely to be many reasons why patients with SLE report poor sleep quality. We have symptoms of fatigue and lethargy, but we did not find any correlation between anaemia and fatigue. A possible shown a moderate correlation between the PSQI and the SF-36 bodily pain score and a weak correlation with explanation for this rather unexpected result is that only a very small proportion of the patients had markedly disease activity scores, suggesting that pain from joints or muscles may disturb sleep. There is also a weak low Hb concentrations. In the majority of cases, however, the cause of fatigue in lupus is unexplained. It is correlation between sleep quality and anxiety and depression, suggesting that these disorders are contributunlikely that one single factor can explain the fatigue in these patients, and it is very likely that many factors ing to poor sleep in at least some of the SLE patients. Medication, particularly steroid therapy, is thought to together lead to lupus fatigue.
lead to poor sleep quality, although we did not show Disease activity any significant difference in sleep quality between patients not taking prednisolone, those on low-dose The relationship between fatigue and disease activity is controversial and research in this area is complicated therapy and those taking >7.5 mg per day. This was probably because the dose of prednisolone was not by the fact that two of the commonly used disease activity measures, SLAM and ECLAM, have fatigue as sufficient to disturb sleep. a component score. Wysenbeek et al. [2] showed a Anxiety and depression correlation between fatigue and a disease activity index and significantly lower lymphocyte counts and C3 levels Abnormal HAD scores, suggesting the presence of anxiety and depression, occurred in a high proportion of in SLE patients with fatigue. Zonana-Nacach et al. [3] also showed a weak but significant correlation between our patients. A third of our patients reported HAD depression scores suggestive of a pathological mood fatigue and disease activity using the SLAM. However, Wang et al. [8] and Bruce et al. [9] showed no significant disorder, which might deserve treatment in its own right. The fact that only 13% of patients were actually taking correlation between FSS and the SLE Disease Activity Index (SLEDAI ), which does not have a fatigue comantidepressants suggests that depression and anxiety may be underdiagnosed in our patient population. The ponent score. We have shown that fatigue scores are significantly higher (up to 33%) in patients who have moderate correlation between HAD depression scores and fatigue indicates that, at least in some patients, more active SLE than in those whose SLE is inactive or quiescent. However, even patients with quiescent SLE depression and anxiety contribute to lupus fatigue. It is often difficult to determine whether mood disreport significant fatigue. In addition, there is only a weak correlation between fatigue and disease activity, order is a manifestation of neuropsychiatric SLE or the result of the stresses associated with a chronic illness or and this becomes weaker when the fatigue component is removed from the disease activity scores, suggesting other major life events. The American College of Rheumatology includes anxiety and mood disorder that the relationship between fatigue and disease activity is neither strong nor linear. These findings are supported within the 19 neuropsychiatric syndromes observed in SLE [23] . However, the case definitions require a clinical by our own clinical experience that patients with active disease complain of increasing severity of fatigue; howevaluation to exclude merely reactive psychological disturbances and suggest that a psychiatric consultation ever, those with inactive disease still continue to report significantly disabling fatigue. may be required. In this study, mood disorder was assessed using the HAD questionnaire only. None of The reason why some groups have shown an association between fatigue and disease activity while others our patients had a mood disorder requiring a psychiatric consultation at the time of the study. It is therefore have not is interesting and may be related to differences in the characteristics of the patient cohorts. The patients difficult to comment on whether the high prevalence of mood disorder present in our patient cohort is a studied by Wang et al. [8] and Bruce et al. [9] were manifestation of neuropsychiatric SLE or merely reflects fatigue should address comorbid mood disorder and sleep disturbance, which are relatively common. their chronic ill health.
